MONFORTE, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.371
EU - Europa 3.336
AS - Asia 1.919
SA - Sud America 954
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 10.647
Nazione #
US - Stati Uniti d'America 4.315
IE - Irlanda 886
BR - Brasile 864
SE - Svezia 714
SG - Singapore 636
CN - Cina 573
UA - Ucraina 572
VN - Vietnam 507
DE - Germania 367
IT - Italia 233
FI - Finlandia 184
GB - Regno Unito 157
RU - Federazione Russa 52
IN - India 47
FR - Francia 36
AT - Austria 34
AR - Argentina 27
CZ - Repubblica Ceca 27
TR - Turchia 27
CA - Canada 23
EC - Ecuador 21
BE - Belgio 20
MX - Messico 20
BD - Bangladesh 17
IQ - Iraq 17
MA - Marocco 16
ZA - Sudafrica 13
IR - Iran 12
UZ - Uzbekistan 12
PL - Polonia 10
CO - Colombia 9
HK - Hong Kong 8
PK - Pakistan 8
CL - Cile 7
KG - Kirghizistan 7
NL - Olanda 7
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
NP - Nepal 6
BO - Bolivia 5
GE - Georgia 5
KE - Kenya 5
PE - Perù 5
RO - Romania 5
UY - Uruguay 5
CH - Svizzera 4
EG - Egitto 4
GR - Grecia 4
LV - Lettonia 4
OM - Oman 4
SN - Senegal 4
VE - Venezuela 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
EU - Europa 3
JO - Giordania 3
KR - Corea 3
PA - Panama 3
PT - Portogallo 3
SA - Arabia Saudita 3
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GA - Gabon 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
NO - Norvegia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.644
Città #
Jacksonville 1.075
Dublin 886
Chandler 745
Dong Ket 507
Nyköping 482
Singapore 377
Beijing 247
Princeton 178
Ashburn 175
Cambridge 170
Medford 167
Dearborn 149
Des Moines 131
Boardman 113
Ann Arbor 86
Wilmington 60
São Paulo 53
Lancaster 49
Los Angeles 49
The Dalles 47
Nanjing 40
Jinan 39
Messina 39
Woodbridge 39
San Mateo 38
Vienna 34
Belo Horizonte 32
Shenyang 32
Milan 27
Brno 26
Munich 23
Haikou 22
Hebei 21
Brasília 19
Brussels 19
Houston 19
Ningbo 19
Rio de Janeiro 19
Pune 18
Zhengzhou 15
Campinas 14
New York 14
Norwalk 14
Tianjin 14
Guangzhou 13
Helsinki 13
Ottawa 13
Taiyuan 12
Augusta 11
London 11
Porto Alegre 11
Tashkent 11
Ardabil 10
Catania 10
Changsha 10
Fuzhou 10
Hyderabad 9
Nanchang 9
Quito 9
Saint Petersburg 9
Seattle 9
Taizhou 9
Auburn Hills 8
Casablanca 8
Frankfurt am Main 8
Hangzhou 8
Hong Kong 8
Indaiatuba 8
Istanbul 8
Monmouth Junction 8
Nuremberg 8
Osasco 8
Uberlândia 8
Asunción 7
Bishkek 7
Brooklyn 7
Duque de Caxias 7
Hefei 7
Nicotera 7
Sorocaba 7
Vitória da Conquista 7
Baghdad 6
Campo Grande 6
Clearwater 6
Curitiba 6
Edinburgh 6
Goiânia 6
Mcallen 6
Recife 6
Ribeirão Preto 6
Santo André 6
Washington 6
Bangalore 5
Caxias do Sul 5
Contagem 5
Falls Church 5
Fortaleza 5
Jiaxing 5
Joinville 5
Juiz de Fora 5
Totale 6.781
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 229
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 170
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 169
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 169
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 163
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 162
1-Adamantanamine derivatives as potential anti-HIV agents 153
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 153
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 102
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 101
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 98
Anti-HIV agents: design and discovery of new potent RT inhibitors 88
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 88
Graphene Quantum Dots Based Systems As HIV Inhibitors 88
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 87
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 87
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 84
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 83
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 82
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 81
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 80
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 79
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 77
Antiretroviral strategy using multi-target agents 77
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 75
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 74
Annelated 1,5-benzothiazepines 73
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 73
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 73
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 72
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 71
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 71
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 70
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 70
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 70
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 69
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 69
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 69
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 68
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 68
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 68
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 67
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 67
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 66
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 66
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 66
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 66
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 66
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 66
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 65
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 65
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 65
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 64
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 64
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 64
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 64
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 63
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 63
Sintesi ed attività anti-HIV di derivati 4-tiazolidinonici. 63
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 63
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 63
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 63
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 62
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 62
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 62
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 61
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 61
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent HIV-1 NNRTIs by molecular modeling studies 61
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 61
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 61
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 61
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 60
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 60
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 60
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 60
Synthesis and structural features of new cyclofunctionalized benzimidazoles 59
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 59
Molecular Modeling, synthesis and SAR of anti-HIV agents 59
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 59
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 59
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 58
Structure-activity relationship of anti-HIV thiazolo[3,4-a]benzimidazole derivatives 58
TBZ-analoghi inibitori non nucleosidici della HIV-RT 58
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 58
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 58
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 58
Progettazione e Sintesi di Nuovi Inibitori dell'Integrasi dell'HIV-1 57
Synthesis and stereochemistry of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3-(2H)-ones 57
SYNTHESIS AND ANTICONVULSANT PROPERTIES OF 3-(1,3,4-THIADIAZOL- 2-YL)THIAZOLIDIN-4-ONES 57
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 57
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 56
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 56
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 56
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 56
Pharmacophore-based design of HIV-1 integrase inhibitors 55
Anti-HIV agents: design and discovery of new potent RT inhibitors 55
Substituent effects on the enantioselective retention of anti- HIV 5-aryl-Delta(2)-1,2,4-oxadiazolines on R,R-DACH-DNB chiral stationary phase 55
SYNTHESIS AND ANTITUMOR-ACTIVITY EVALUATION OF 1- [(ARYLIDENE)AMINO]ADAMANTANES 55
LFER AND COMFA STUDIES ON OPTICAL RESOLUTION OF ALPHA-ALKYL ALPHA-ARYLOXY ACETIC-ACID METHYL-ESTERS ON DACH-DNB CHIRAL STATIONARY-PHASE 54
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 54
Totale 7.527
Categoria #
all - tutte 41.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020409 0 0 0 0 0 0 0 0 0 174 231 4
2020/20211.576 160 2 230 30 22 154 8 169 14 142 109 536
2021/20221.057 14 229 26 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/20252.125 54 35 73 212 114 100 31 666 760 80 0 0
Totale 10.784